Keywords: patent, expiries, threaten, 22b, cns, drug, sales

Patent expiries threaten $22B of CNS drug sales, says URCH

Article | 18 June 2007

Print This

Just three of the 13 patented drugs that dominated the global market for central nervous system treatments in 2005 will be free ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in